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Abstract
Online  hemodiafiltration  (OL-HDF)  as  a  renal  replacement  therapy  is  gaining
momentum due to the perceived added benefit from enhanced clearance of potential‐
ly harmful middle molecules. Favorable effect of OL-HDF on all-cause mortality and
cardiovascular mortality and morbidity has been suggested by some clinical trials.
Health-related quality of life (HRQOL) is an important component of hemodialysis
patients’  care.  HRQOL  is  of  interest  to  both  health  care  providers  and  patients.
Improved quality of life in hemodialysis patients has been associated with improved
outcome in terms of reduced rate of hospitalization and mortality. Data on HRQOL in
end-stage renal  disease  (ESRD) patients  under  OL-HDF is  scarce  and of  marginal
quality. In this review, we will try to summarize the available evidence on this subject.
Keywords: Quality of life, Health-related quality of life, Online hemodiafiltration, He‐
modiafiltration, End-stage renal disease
1. Introduction
End-stage renal disease (ESRD) is characterized by significantly increase rate of mortality and
morbidity. Survival of patients with end-stage renal disease is substantially decreased com‐
pared to counterparts without renal failure. It is estimated that 10–20 % of dialysis patients die
annually [1]. Historically, in patients with ESRD, survival has been commonly utilized as a
measure of outcome, as both health care providers and patients are most interested in prolong‐
ing life.
Quality of life (QOL) is curtailed in these patients not only due to the physical burden of the
disease but also due to its effect on psychological, social interaction, rehabilitation, and
employment component of patient life. Renal replacement therapy decreases morbidity related
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to uremia and improves many of the uremic symptoms such as anorexia, fatigue, and pruritus
that have a negative impact on the quality of daily life.
Conventional hemodialysis (HD) is reasonably effective in removing small solutes by way of
diffusion across membranes. However, middle molecules which are implicated in adverse
outcome are poorly removed by such mechanism. Secondary analysis of the HD trial had
suggested that survival may depend on clearance of such middle molecules [2]. Convective
therapy is more effective in removing larger toxic middle molecules such as β2-microglobulin.
High-volume online hemodiafiltration (OL-HDF) effectively achieves significant clearance of
middle molecules. Such treatment has been shown to be beneficial in terms of lower risk of
all-cause and cardiovascular mortality when compared to standard hemodialysis. Secondary
analysis of initially negative clinical trials also demonstrated decreased mortality in recipients
of high-volume OL-HDF [3–7].
Hemodiafiltration (HDF) combines diffusive and convective clearance of uremic solutes. It
involves convection of large volume of fluid and infusing in the patient a replacement fluid
that is ultrapure, sterile, and free of pyrogens. Utilization of online HDF where replacement
fluid is prepared by further purifying dialysate fluid instead of manufacturer-provided
solutions made it more practical and cost effective. It is believed that high-volume HDF by
increasing clearance of middle molecules could potentially improve symptomatology, reduces
morbidity, and may even improve survival [8]. These in turn could result in improved quality
of life. Improved quality of life in hemodialysis patients has been associated with improved
outcome. Analysis of data using the Kidney Disease Quality of Life Short Form (KDQOL-
SFTM) obtained from 10,030 randomly selected hemodialysis patients from the USA, five
European countries and Japan in the Dialysis Outcomes and Practice Patterns Study (DOPPS)
demonstrated associations between HRQOL and the risk of death and hospitalization. Scores
were determined for three components of HRQOL: (1) physical component summary (PCS),
(2) mental component summary (MCS), and (3) kidney disease component summary (KDCS).
Lower scores for the three major components of HRQOL were strongly associated with higher
risk of death and hospitalization in hemodialysis patients, independent of a number of
demographic and comorbid factors [9].
Information on quality of life in patients receiving renal replacement therapy in the form of
OL-HDF is scarce and inconclusive. The studies often involve small sample size and uses
different methods of quantifying HRQOL. In this report, we will attempt to address HRQOL
in patients under OL-HDF treatment by way of defining HRQOL, describing the most common
instruments used to evaluate HRQOL and presenting brief summaries of clinical studies that
investigated HRQOL in individuals receiving convective therapy.
2. What is health-related quality of life (HRQOL)
The concept of HRQOL has been around for many decades. In its constitution, the World
Health Organization has defined health as “a state of complete physical, mental and social
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well-being and not merely the absence of disease or infirmity” [10]. Quality of life (QOL) is a
broad multidimensional concept that usually includes subjective evaluations of both positive
and negative aspects of life [11]. It is often defined differently by variable groups and profes‐
sional societies. This adds to the difficulty of measuring QOL. Health constitutes an important
component of QOL assessment. However, other parameters such as employment, education,
housing, and family life are important contributors to the overall QOL. Cultural and religious
beliefs and values also add to the complexity of assessing quality of life.
The World Health Organization defines QOL as “an individual’s perception of their position
in life in the context of the culture and value system where they live, and in relation to their
goals, expectations, standards, and concerns” [12]. Assessment of quality of life should
encompass not only the physical condition but also factors that have an impact on the
individual’s well-being such as social, economic, emotional, and psychological factors. Quality
of life and health are closely related. Each can have a positive or a negative impact on the other
depending on condition. Such a relationship is demonstrated by the notion that greater
survival is associated with a higher-measured QOL [13, 14].
Assessments of HRQOL have evolved over the years to include aspects of overall quality of
life that can be obviously shown to affect physical as well as mental health (MH) [15–17].
On the individual level, this includes physical and mental health perceptions and their
correlates including health risks and conditions, functional status, social support, and socioe‐
conomic status. On the community level, HRQOL includes resources, conditions, policies, and
practices that influence a population’s health perceptions and functional status. The construct
of HRQOL enables health agencies to legitimately address broader areas of public health policy
in collaboration with a wider circle of health partners, including social service agencies and
community planners.
HRQOL questions about perceived physical and mental health and function have become an
important component of health surveillance and are generally considered valid indicators of
service needs and intervention outcomes. Self-assessed health status also proved to be a more
powerful predictor of mortality and morbidity than many objective measures of health [9].
The measurement of QOL should encompass many factors that affect a subject’s well-being.
It should include not just the physical aspect but also the social, emotional, intellectual, and
cultural components that comprise daily life. According to this foundation, we can define an
aspect of QOL as being health related. This health-related quality of life (HRQOL) represents
the “physical, psychological, and social domains of health that are influenced by a person’s
experience, beliefs, expectations, and perceptions” [18]. Each of these domains can be meas‐
ured in two dimensions, objective assessments of functioning status and subjective perceptions
of health as reported by the individual. The patient’s subjective attitudes and expectations
convert that objective assessment into the actual quality of life [10].
Within this context, health is defined as not only the absence of disease and infirmity but also
the presence of physical, mental, and social well-being [11].
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3. Measuring health-related quality of life
Adequate HRQOL measurement instrument should capture all the effects that disease and its
treatment have on the physical, emotional, social, and mental dimensions of an individual [19].
An ideal instrument would be comprehensive, reliable, and of proven validity and would
facilitate comparisons between groups of subjects with different illnesses and within the same
group receiving different modes of treatment. The extracted HRQOL measures must be
converted into a numerical value for proper utilization.
There is no one ideal tool of measuring HRQOL, and therefore, multiple different instruments
have been developed.
Most of these instruments use a series of questions to assess quality of life indirectly. These
questions are defined as “items.” Each item is then given a numerical value, based on a
predetermined scale. Most researchers measure each quality-of-life domain separately, by
asking specific questions pertaining to its most important components.
HRQOL instruments can be subdivided into categories based on whether the tool is global or
domain specific. Three major domains comprise global HRQOL: the physical domain, the
social domain, and the psychosocial or mental domain.
Many schemes have been developed to assess QOL in individuals with end-stage renal disease.
Here, we will briefly describe the most common tools used in assessing HRQOL in studies
involving patients under treatment by OL-HDF.
Domain Meaning of low score Meaning of high score Number of
questions
Physical functioning
(PF)
Severe limitations in physical activity,
including bathing and dressing
Performs vigorous activity without
limitations
10
Role-physical (RP) Limited ability to work because of
physical health
Physical health does not limit work or
other activities
4
Bodily pain (BP) Severe limiting pain No pain or limitations due to pain 2
General health (GH) Perceives health as poor Perceives health as excellent 5
Vitality (VT) Feels tired and worn out all the time Feels full of pep and energy all the time 4
Social functioning (SF) Physical and emotional symptoms
severely limit normal social activities
No physical or emotional limits to
normal social activities
2
Role-emotional (RE) Emotions limit daily function and
work
Emotions do not interfere with daily
function or work
3
Mental health (MH) Feels nervous and depressed all the
time
Feels peaceful, happy, and calm all the
time
5
Ref. [25].
Table 1. Components of the Short Form-36 (SF-36).
Advances in Hemodiafiltration126
3.1. Kidney Disease Quality of Life (KDQOL) Short Form-36 (SF-36)
The Kidney Disease Quality of Life (KDQOL) instrument is a self-report questionnaire
consisting of 134 items [20]. It has the SF-36 as its generic core and is supplemented with items
of relevance to the HRQOL of dialysis patients. Disease-specific items assess symptoms/
problems, effects of kidney disease on daily life, burden of kidney disease, cognitive function,
work status, sexual function, quality of social interaction, and sleep. Included are also items
relating to social support, encouragement from dialysis staff, patient satisfaction with care,
and a global rating of health. A more practical shorter version, the KDQOL-SF, was developed
later in view of the length of the original one. The KDQOL-SF includes the SF-36 supplemented
with 43 disease-specific items from the domains identified in the original version [21].
The KDQOL-SF is easy to administer and has been validated and used widely with hemo‐
dialysis (HD) patients. KDQOL-SF became the most widely used QOL measure for ESRD
patients. It was developed in the USA for dialysis patients and has been translated into several
languages, to be used in several studies involving dialysis patients [22–24].
The SF-36 Health Survey can be self-reported or obtained with the help from a health profes‐
sional in patients unable to complete the survey. The SF-36 contains only 36 items, through
which it evaluates eight health concepts of HRQOL. The eight health concepts are physical
functioning (ten items), role limitations resulting from physical problems (four items), role
limitations caused by emotional or personal problems (three items), social functioning (two
items), bodily pain (BP) (two items), energy/fatigue (four items), emotional well-being (five
items), and general health (GH) perceptions (five items). In addition, there is one single item
that provides an indication of perceived change since 1 year. Two additional components can
be calculated from the SF-36, and they are the physical component summary (PCS) and the
mental component summary (MCS). A higher score is associated with a more favorable health
status. Components of the SF-36 are depicted in Table 1.
3.2. The Kidney Disease Questionnaire (KDQ) of Laupacis et al. (Canada) [26]
In 1992, Laupacis developed this tool which is disease-specific designed for use in chronic HD
patients. The KDQ consists of 26 items in five dimensions: physical symptoms (six items),
fatigue (six items), depression (five items), relationships (six items), and frustration (three
items). The physical symptoms dimension of the KDQ is patient specific. The six physical
symptoms that are most important to each subject are identified and used to assess that
dimension. Patients are asked to identify their specific physical problems, next to questions
regarding frustration, depression, and well-being. Patients are asked to grade their complaints
on a scale ranging from one (severe) to seven (none). The KDQ is designed for use only in
patients with ESRD on HD treatment.
3.3. The Euro Quality of Life Group (EQ-5DTM) questionnaire
The EQ-5DTM measures health-related quality of life in five dimensions: mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression. Scores for the five dimensions are
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converted into preference weights by using country-specific value sets drawn from the general
population [27].
This instrument is rather new; therefore, only few country-specific value sets are available.
3.4. The CHOICE Health Experience Questionnaire (CHEQ) [28]
This is a patient-reported measure of HRQOL developed for use in the Choices for Healthy
Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study [29]. The authors have
defined it as “the value assigned to duration of life as modified by the impairment, functional
states, perceptions, and social opportunities that are influenced by disease, injury, or policy.”
This instrument was developed to evaluate the effectiveness of alternative dialysis prescrip‐
tions. It supplements SF-36 survey in measuring HRQOL for patients with ESRD. It is sensitive
to differences in dialysis modality and dialysis dose. The selection of HRQOL domains to be
utilized was based on literature review, analysis of focus groups, and survey of dialysis
providers and patients. In order to arrange domains and items identified, a representative
sample of 136 dialysis patients rated each item for frequency and distress. The survey yielded
22 HRQOL domains that included 96 items: eight generic domains in the SF-36 (health
perceptions, physical, social, physical and emotional role functions, pain, mental health, and
energy), eight additional generic domains (cognitive functioning, sexual functioning, sleep,
work, recreation, travel, finances, and general quality of life), and six ESRD-specific domains
(diet, freedom, time, body image, dialysis access, and symptoms).
4. Trials on quality of life in HDF
The results of studies on HRQOL in OL-HDF are often inconclusive. The studies used different
questionnaires to assess HRQOL which probably explain some of the differences among
studies.
Reference Country Comparison Quality-of-life
instrument used
Timing of
assessment
Study result
Moura et al.
[38]
Portugal Four age
quartiles
(<56 years,
57–68 years, 69–75
years, >75 years
old)
KDQOL-SF
version 1.3 for
Portuguese
patients
One time at
baseline
Women >56 years old had decrease in
work status, patient satisfaction, and
role-physical. Men had decreasing
physical functioning, with increasing
age. Compared to women, men
generally had higher scores in all
quartiles on variable combinations of
physical functioning and pain, patient’s
satisfaction, symptoms/problem list,
work status, role-physical, emotional
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Reference Country Comparison Quality-of-life
instrument used
Timing of
assessment
Study result
well-being, work status, energy/fatigue,
and quality of social interactions
Karkar et al.
[32]
Saudi Arabia HF-HD and OL-
HDF
Modified
KDQOL-SF
version 1.3
24 months OL-HDF was associated with
improvement in general mood, body
energy, dialysis compliance, sexual
performance, social activity, and
patient’s satisfaction
Moura et al.
[43]
Portugal Access type:
AVF vs. CVC
KDQOL-SF
version 1.3 for
Portuguese
patients
One time at
baseline
Patients with CVC had a decrease in
scores of physical functioning,
emotional well-being, role emotional,
and energy/fatigue domains when
compared with those with AVF.
Patients with CVC also showed a
decline in cognitive function and
quality-of-social interaction domains.
Nondiabetic patients generally scored
better than diabetic patients with
similar vascular access
Mazairac et
al. [37]
The
Netherlands,
Canada, and
Norway
OL-HDF and
LF-HD
KDQOL-SF-36
version 1.3
At baseline
and Q
3 months for
a median of
2 years
At baseline, mean PCS and MCS were
similar in both groups. In both groups,
multiple HRQOL domain scores
declined over time. Overall health
domain improved in HDF patients. A
trend to a worse MCS and an improved
effect of kidney disease on daily life in
patients on HDF
Kantartzi et
al. [33]
Greece LF-HD vs. OL-
HDF and HDF
(with prepared
bags)
IQOLA SF-36
Greek version
Q 3 months
for 1 year
OL-HDF and HDF had better score in
bodily pain and role limitations due to
emotional functioning. There were no
differences between the two types of
hemodiafiltration
Knezevic et
al. [31]
Serbia OL-HDF vs. HF-
HD and LF-HD
KDQOL-SF-36 One time at
baseline
No difference in general health domain.
Patients on HDF had better score in
most of the domains compared with
patients on HD, especially compared
with low-flux HD patients. No
differences between high-flux HD and
low-flux HD
Age, economic status, dialysis modality,
and ischemic heart disease were
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Reference Country Comparison Quality-of-life
instrument used
Timing of
assessment
Study result
associated with PCS. Age, sex,
economic status, dialysis modality, and
vascular access are associated with MCS
Stefánsson et
al. [40]
Sweden OL-HDF vs. LF-
HD
IQOLA SF-36
(Swedish
version) + local
questionnaire
60 days With the exception of a lower score for
social functioning with HDF, there was
no significant difference in quality of
life between HD and HDF
Schiffl [34] Germany HF-HD vs. OL-
HDF
KDQ 52 weeks Patients in the two treatment groups
had similar perceptions of their quality
of life. While on OL-HDF, patients had
sustained improvement in physical
symptoms. No change of this
dimension with the other mode of
therapy
Beerenhout
et al. [39]
The
Netherlands
OL-HF vs.
LF-HD
KDQ At baseline,
6 and
12 months
Physical symptoms improved in the HF
group after 6 and 12 months, but not in
the HD group. QOL for other aspects
(frustration, depression, well-being) did
not change in any treatment group
Lin et al. [44] Taiwan OL-HDF vs. HF-
HD (different
combinations)
Patients’ score of
subjective well-
being, work
tolerance, and
mental alertness
Weekly Interdialytic symptomatic hypotensive
episodes and interdialysis physical
well-being and symptoms improved
when frequency of HDF is increased to
three times per week
Ward et al.
[41]
Germany OL-HDF vs. HF-
HD
The Kidney
Disease
Questionnaire
26 and
52 weeks
Both groups had similar perceptions of
their quality of life. Patients’ assessment
of physical symptoms improved during
the course of the study independent of
mode of therapy
Verzetti et al.
[42]
Italy AFB vs. BHD in
patients with
diabetic ESRD
Patients’ score of
their degree of
subjective well-
being
Monthly Subjective report of well-being
increased when patients switched from
traditional HD to AFB
Abbreviations: AFB, acetate-free biofiltration; AVF, arteriovenous fistula; BHD, bicarbonate hemodialysis; CVC, central
venous catheter; HDF, hemodiafiltration; HF, hemofiltration; HF-HD, high-flux hemodialysis; IQOLA, International
Quality of Life Assessment; KDQOL, Kidney Disease Quality of Life; KDQ, Kidney Disease Questionnaire; LF-HD,
low-flux hemodialysis; MCS, mental component summary; OL-HDF, online hemodiafiltration; OL-HF, online
hemofiltration; PCS, physical component summary; SF-36, Short Form-36.
Table 2. Summary of studies assessing QOL in patients treated with convective therapy.
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The following is the description of trials that examined HRQOL in patients under treatment
of OL-HDF, hemofiltration (HF), and acetate-free biofiltration (AFB) in comparison to low-flux
hemodialysis (LF-HD) or high-flux hemodialysis (HF-HD). Summary of these trials is
presented in Table 2.
4.1. Moura et al.
Moura et al. performed an evaluation of 322 ESRD under OL-HDF from five dialysis units in
north Portugal in which patients reported HRQOL utilizing the Kidney Disease Quality of Life
Short Form (KDQOL-SF). Patients showed a mean (±SD) of 53.17 % (±15.31 %) in SF-36 total
score, 50.17 % (±9.51 %) in the SF-36 mental component summary (MCS), and 49.75 % (±9.44 
%) in the SF-36 physical component summary (PCS). Red cell distribution width (RDW), female
gender, and diabetes were found as significant predictors of SF-36 total score of HRQOL, which
accounts for 12 % of the total explained variance. Patient satisfaction, RDW, body mass index,
and gender were identified as predictors for the PCS, which accounts for 22 % of total explained
variance. Furthermore, patient satisfaction and dry weight were found as predictors for MCS.
These predictors accounted for 28 % of the total explained variance. The authors concluded
that the coexistence of diabetes, female gender, and anemia are predictors of HRQOL in
patients under OL-HDF and suggest that more attention should be given to these issues in
order to improve HRQOL [30]
4.2. Knezevic et al.
Knezevic et al. examined whether hemodialysis modality and membrane flux, independent of
membrane biocompatibility, make differences in quality of life in 124 patients from Serbia. The
patients were divided, based on therapy, into three groups: online HDF, high-flux hemodial‐
ysis, and low-flux hemodialysis. Health-related quality of life was assessed using the Short
Form-36 questionnaire combined with special questionnaire, which included demographic
and clinically related questions. Health-related quality of life was better in patients on HDF
compared with patients on hemodialysis, especially compared with low-flux hemodialysis
patients in most of the scales and in both dimensions: physical component scale and mental
component scale. There were no differences in Short Form-36 domains between high-flux
hemodialysis and low-flux hemodialysis. The conclusion was that HDF has a potential positive
influence on quality of life, which is sufficient to justify further research in prospective and
longitudinal study design [31].
4.3. Karkar et al.
Karkar et al. investigated the effect of online HDF vs. high-flux hemodialysis (HF-HD) on a
patient’s health-related satisfaction level. The study involved 72 patients from Saudi Arabia
on regular low-flux HD who were randomized to HF randomized to HF-HD and to HDF
(n = 36) and followed up for 24 months. Satisfaction level was assessed using modified
questionnaires of the Kidney Disease Quality of Life Short Form (KDQOL-SF) version 1.3. The
HDF group achieved a higher satisfaction level than the HD group (P < 0.0001) with less
cramps, itching, joint pain, and stiffness. There was an improvement in general mood, sexual
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performance, and social activity. The investigators concluded that high-efficiency postdilution
online HDF significantly improved patients’ satisfaction level and quality of life [32].
4.4. Kantartzi et al.
Kantartzi et al. reported a prospective crossover study involving 24 patients. Each patient
received HD, OL-HDF, and HDF with prepared bags of substitution fluid for 3 months, with
the dialysis modality subsequently being altered. Quality of life was measured by the Short-
Form Health Survey with 36 questions (SF-36), and subscale scores were calculated. There were
statistical significant differences in QOL for the total SF-36, bodily pain score, and role
limitations due to emotional functioning in favor of online HDF over low-flux HD [33].
4.5. Schiffl
Schiffl studied 76 clinically stable patients on low-flux conventional HD (LF-HD) in a pro‐
spective crossover clinical evaluation of high-flux ultrapure hemodialysis (HF-HD) and OL-
HDF. They were randomized to HF-HD or OL-HDF (24 months) and switched to the
alternative treatment (24 months). Online HDF had a greater clearance of urea, phosphate, and
β2-microglobulin. Both OL-HDF and high-flux ultrapure HD significantly improved nutri‐
tional status and the response to erythropoietin. Disease-related quality of life was determined
after 52 weeks of each study period using the KDQ. The KDQ determines quality of life in five
dimensions: physical symptoms, fatigue, depression, relationship with others, and frustration.
The patients in the two treatment groups had similar perceptions of their quality of life.
However, the patients’ assessment of their physical symptoms showed a sustained improve‐
ment during treatment with OL-HDF. There was no change of this dimension with the other
modes of therapy (P < 0.05). None of the other dimensions of the Kidney Disease Questionnaire
showed a change during the course of the study [34].
4.6. Mazairac et al.
Mazairac et al. analyzed data of 714 patients from the Convective Transport Study [35, 36] with
a median follow-up of 2 years to assess the effect of HDF on quality of life compared with HD
in patients with ESRD. Quality of life was assessed with the KDQOL-SF. There were no
significant differences in changes of HRQOL over time between patients treated with HD
(n = 358) or hemofiltration (n = 356) [37].
4.7. Moura et al.
Moura et al. evaluated the influence of aging on patients’ perception of HRQOL in 305 ESRD
patients under OL-HDF. Data about comorbidities, hematological data, iron status, dialysis
adequacy, and nutritional and inflammatory markers were collected from patient’s records.
Quality of life was assessed by using the KDQOL-SF. Analysis of the data showed significant
decrease with increasing age in some parameters evaluated by the KDQOL-SF instrument,
namely, for work status, physical functioning, and role-physical (RP) [38].
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4.8. Beerenhout et al.
Beerenhout et al. examined the effects of LF-HD and predilution online HF (OL-HF) on
cardiovascular and nutritional parameters, interdialytic levels of uremic toxins, and quality of
life. The KDQ of Laupacis [26] was used for QOL assessment. At 1 year, 27 patients were eligible
for analysis (HF, 13 patients; HD, 14 patients). QOL for physical symptoms improved in the
HF group (4.2 ± 1.2–5.0 ± 1.1), P < 0.05 within the HF group, but not in the HD group (4.0 ± 1–
4.4 ± 1.4) [39].
4.9. Stefánsson et al.
Stefánsson et al. performed a prospective, randomized, and patient-blinded crossover study
involving 20 patients from Sweden on chronic HD. The patients received either HD for
2 months followed by postdilution HDF for 2 months or in opposite order. Online postdilution
HDF was used, and the replacement volume was standardized to 25–30 % of the total blood
volume treated. The two treatments were similar with respect to dialysis-related complica‐
tions, quality of life, and the biomarkers of oxidative stress and inflammation. Interviews for
assessment of quality of life were double blinded. Patients answered health-related questions
in two separate questionnaires. The first one was the Swedish version of the standardized
quality-of-life questionnaire, SF-36. The second one was generated by the study designers and
specifically concerned 12 symptoms and health-related conditions occurring during the
previous 4 weeks. With the exception of a lower score for social functioning with HDF (P < 0.05),
there was no significant difference in quality of life between HD and HDF [40].
4.10. Ward et al.
Ward et al. tested the hypothesis that HDF provides better solute removal than HF-HD in a
prospective, randomized clinical trial. Twenty-four patients were randomized to online
postdilution HDF, and twenty-one patients were allocated to HF-HD for a period of 12 months.
Removal of both small (urea and creatinine) and large (β2-microglobulin and complement
factor D) solutes was significantly greater for HDF than for HF-HD. Pretreatment plasma β2-
microglobulin concentrations decreased with time (P < 0.001); however, the decrease was
similar for both therapies. The patients’ assessment of their quality of life was determined after
26 and 52 weeks of the study. A single interviewer administered the questionnaire to all
patients. The patients in both groups had similar perceptions of their quality of life as assessed
by the KDQ. The patients’ assessment of their physical symptoms showed a significant
improvement during the course of the study which was independent of the treatment
modality. None of the other dimensions of the KDQ showed a change over the course of the
study [41].
4.11. Verzetti et al.
Verzetti et al. performed a study to compare standard bicarbonate hemodialysis (BHD) with
acetate-free biofiltration (AFB) in a group of 41 stable diabetic patients on dialysis treatment
for 25 ± 22 months. Twenty-four type II and seventeen type I diabetic patients, all requiring
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insulin therapy, were included and were followed up for 1 year in a 6-month crossover
randomized study for both methods. The analysis was carried out on dialysis symptoms,
interdialysis symptoms, and nutritional status. On a monthly basis, patients were also required
to score their degree of subjective well-being. All the clinical events occurring during the study
period, together with the number of hospitalizations and mortality rates, were recorded. AFB
significantly reduced dialytic and extra-dialytic symptoms (P = 0.003 and 0.001, respectively).
Cardiovascular collapses decreased by 43 %, and other dialysis symptoms showed a similar
trend (−35 %). The interdialysis symptoms decreased by 28 % and were accompanied by an
increase in subjective well-being (39 %) when patients were switched from traditional HD to
AFB. Acid-base control was better with AFB (P = 0.01), both at the beginning and during the
session. In comparison to traditional HD, hypotensive episodes and other dialysis symptoms
during AFB decreased by 43 % and 35 %, respectively. Interdialysis symptoms showed the
same favorable trend, decreasing by 28 %. Moreover, subjective report of well-being increased
by 39 % when the patients switched from traditional HD to AFB. The number of hospital
admissions and the mortality rate were lower during the AFB than the BHD period. The
authors concluded that AFB allows better control of some metabolic aspects, reduces intra-
and extra-dialysis symptoms, and improves patient QOL [42].
4.12. Moura et al.
Moura et al. examined the effect of vascular access type (arteriovenous fistula (AVF) vs. central
venous catheter (CVC)) on patients reported HRQOL in 322 ESRD under OL-HDF. Arterio‐
venous fistula (AVF) was used by 252 patients (78.3 %), whereas 70 patients (21.7 %) had a
central venous catheter (CVC). Patients using CVC as a vascular access presented a decrease
in four SF-36 domain scores, namely, physical functioning, emotional well-being, role-
emotional, and energy/fatigue when compared with those using AVF as a vascular access.
Additionally, these patients also showed significant decline in cognitive function and quality-
of-social interaction domains. Left-arm AVF was associated with higher scores in three SF-36
domain scores, namely, physical functioning, pain, and general health. It was also associated
with a higher score in ESRD target areas of symptoms/problem list and effects of kidney disease
and quality-of-social interaction domains. The authors concluded that ESRD patients under
OL-HDF using AVF as a vascular access had higher HRQOL scores in several domains when
compared with those using CVC. Patients using AVF in the left forearm presented with higher
HRQOL scores [43].
4.13. Lin et al.
Lin et al. compared OL-HDF (thrice, twice, and once per week) with different frequencies of
combination high-flux HD. Interdialytic symptomatic hypotensive episodes were reduced
when frequencies of online HDF were increased. Interdialysis physical well-being and
symptoms similarly improved when frequency of HDF is increased to three times per week
[44].
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4.14. Nistor I et al.
Nistor et al. [45] conducted a systematic review of randomized controlled trials in which data
for quality of life were extractable from eight trials (988 participants), including six evaluating
HDF and one each evaluating HF or acetate-free biofiltration [33, 34, 36, 39–42, 44]. The authors
Stated that in very low-quality evidence, data for quality of life were inconsistent. Data from
the four parallel-group trials [33, 36, 39, 41] showed that there was no difference in the change
in quality of life (any domain) comparing HDF with HD in one trial [36]. Both HDF and HD
patients reported significant improvement in physical symptoms irrespective of treatment
allocation in a second trial [41]. Hemodialysis patients had lower physical well-being scores
than patients on HDF, but treatment effects on work tolerance and mental alertness were not
available in a third trial [33]. Comparative data for HF and HD were not available in a fourth
trial [39]. The remaining four studies were crossover design, and data for the end of the first
phase of treatment were not available.
5. Summary
The available data on HRQOL in patients under OL-HDF therapy is limited and of low quality.
Most parallel-group randomized clinical trials on this subject demonstrate no or limited
improvement in HRQOL associated with OL-HDF. However, several crossover studies
support a beneficial role of OL-HDF in enhancing quality of life in these patients. The effect of
online HDF on quality of life reported by clinical studies is variable. The inconsistency of these
results is probably related to different methods used to assess quality of life, sample size,
duration of study, and the different characteristics of the convective therapy utilized such as
blood flow rate, vascular access type and type of the dialyzer, convection volume, and
frequency of online HDF. The most widely used and tested method of assessing health-related
quality of life in patients undergoing online HDF replacement therapy is Kidney Disease
Quality of Life Short Form-36 (KDQOL-SF-36). It is easily administrable and has been vali‐
dated.
With the increased popularity of OL-HDF as a renal replacement therapy, larger better
organized studies will probably become available in the future. Such studies, hopefully, will
better clarify the issue.
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